NEU 7 Jan 2026, 10:20 AM

NNZ-2591 PMS Phase 2 trial published in Neurology Genetics

Neuren Pharmaceuticals Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in